Overview of CAPE
The Cancer Advocacy & Patient Education (CAPE) initiative aims to create a web-based library of best-practice information that providers in the CLL cancer space can give to their patients and caregivers at each point of interaction. This program is supported by funding from Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc.
To improve patient experience from cancer diagnosis through the cancer trajectory with personalized education
Engage, inform, and empower newly diagnosed cancer patients utilizing a predetermined quality-of-life model to reduce distress and improve patient experience from diagnosis through the cancer trajectory.